• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV

CLEO DIAGNOSTICS LTD - Corporate Spotlight

3.85% ! 37.5¢
Market Cap $30.6M  !

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. Triage Test is a pre-surgical test to determine ovarian or adnexal mass for which surgical referral is required who have not yet been referred to an oncologist.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
37.5¢
Change
-0.015(3.85%)
Mkt cap ! $30.6M
Open High Low Value Volume
39.0¢ 39.0¢ 37.5¢ $57.09K 150.4K

Buyers (Bids)

No. Vol. Price($)
3 28671 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 25000 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
COV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.